179 related articles for article (PubMed ID: 37715293)
1. Prevalence and factors associated with pentavalent vaccination: a cross-sectional study in Southern China.
Xu J; Cui Y; Huang C; Dong Y; Zhang Y; Fan L; Li G; Jiang F
Infect Dis Poverty; 2023 Sep; 12(1):84. PubMed ID: 37715293
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
Klein NP; Abu-Elyazeed R; Cheuvart B; Janssens W; Mesaros N
Hum Vaccin Immunother; 2019; 15(4):809-821. PubMed ID: 30444673
[TBL] [Abstract][Full Text] [Related]
3. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
Johns TL; Hutter GE
Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of a DTaP-IPV/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan.
Nakayama T; Vidor E; Tsuzuki D; Nishina S; Sasaki T; Ishii Y; Mizukami H; Tsuge H
J Infect Chemother; 2020 Jul; 26(7):651-659. PubMed ID: 32307307
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
[TBL] [Abstract][Full Text] [Related]
6. Cost-minimization analysis of DTaP-IPV-Hib combination vaccine in China: A nationwide cross-sectional study.
Liu B; Cao B; Wang C; Sun T; Miao Y; Zhang S; Zhao T; Cui F
J Med Virol; 2023 Jan; 95(1):e28358. PubMed ID: 36448181
[TBL] [Abstract][Full Text] [Related]
7. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
[TBL] [Abstract][Full Text] [Related]
8. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.
Schmitt HJ; von Kries R; Hassenpflug B; Hermann M; Siedler A; Niessing W; Clemens R; Weil J
Pediatr Infect Dis J; 2001 Aug; 20(8):767-74. PubMed ID: 11734739
[TBL] [Abstract][Full Text] [Related]
9. Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination.
Rennels MB; Englund JA; Bernstein DI; Losonsky GA; Anderson EL; Pichichero ME; Munoz FM; Wolff MC
Pediatr Infect Dis J; 2000 May; 19(5):417-23. PubMed ID: 10819337
[TBL] [Abstract][Full Text] [Related]
10. Timing of Monovalent Vaccine Administration in Infants Receiving DTaP-based Combination Vaccines in the United States.
Marshall GS; Petigara T; Liu Z; Wolfson L; Johnson D; Goveia MG; Chen YT
Pediatr Infect Dis J; 2022 Sep; 41(9):775-781. PubMed ID: 35763699
[TBL] [Abstract][Full Text] [Related]
11. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.
Pedersen KB; Holck ME; Jensen AKG; Suppli CH; Benn CS; Krause TG; Sørup S
Scand J Public Health; 2020 Feb; 48(1):96-105. PubMed ID: 30024308
[No Abstract] [Full Text] [Related]
12. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
[TBL] [Abstract][Full Text] [Related]
13. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants.
Yeh SH; Ward JI; Partridge S; Marcy SM; Lee H; Jing J; Curry ES; Howe BJ
Pediatr Infect Dis J; 2001 Oct; 20(10):973-80. PubMed ID: 11642632
[TBL] [Abstract][Full Text] [Related]
15. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
Martinón-Torres F; Halperin SA; Nolan T; Tapiéro B; Perrett KP; de la Cueva IS; García-Sicilia J; Stranak Z; Vanderkooi OG; Kosina P; Rumlarova S; Virta M; Arribas JMM; Miranda-Valdivieso M; Novas BA; Bozensky J; Ortega MJC; Amador JTR; Baca M; Palomino EE; Zuccotti GV; Janota J; Marchisio PG; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Mesaros N
Vaccine; 2021 Mar; 39(11):1598-1608. PubMed ID: 33612341
[TBL] [Abstract][Full Text] [Related]
16. Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017.
Li Z; Xu J; Tan H; Zhang C; Chen J; Ni L; Yun X; Huang Y; Wang W
Int J Infect Dis; 2020 Oct; 99():149-155. PubMed ID: 32795602
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.
Greenberg DP; Doemland M; Bettinger JA; Scheifele DW; Halperin SA; ; Waters V; Kandola K
Pediatr Infect Dis J; 2009 Jun; 28(6):521-8. PubMed ID: 19436236
[TBL] [Abstract][Full Text] [Related]
18. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.
Sun Y; Christensen J; Hviid A; Li J; Vedsted P; Olsen J; Vestergaard M
JAMA; 2012 Feb; 307(8):823-31. PubMed ID: 22357833
[TBL] [Abstract][Full Text] [Related]
19. The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants.
Kang JH; Lee HJ; Kim KH; Oh SH; Cha SH; Lee J; Kim NH; Eun BW; Kim CH; Hong YJ; Kim HH; Lee KY; Kim YJ; Cho EY; Kim HS; Guitton F; Ortiz E
J Korean Med Sci; 2016 Sep; 31(9):1383-91. PubMed ID: 27510380
[TBL] [Abstract][Full Text] [Related]
20. Cost-Minimization and Budget Impact Analysis of a Hexavalent Vaccine (Hexaxim®) in the Colombian Expanded Program on Immunization.
Romero M; Góngora DS; Caicedo ML; Benchabane D; Lopez JG
Value Health Reg Issues; 2021 Dec; 26():150-159. PubMed ID: 34474265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
